BioSpace News Archive

CHC Health, announced today that former Humana/CVS Health executive, Andy Papa, has joined their C-suite management team as the Chief Revenue Officer.

The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced its expected revenue for the fiscal fourth quarter ended June 30, 2019 and provided guidance for fiscal 2020

Paula has agreed to join InMode Ltd. (Nasdaq: INMD) (“InMode” or the “Company”) as a brand ambassador to share her positive experience with the Company’s BodyTite, FaceTite and Morpheus8 technologies.

Kiva Sales and Service (KSS), the industry-leading sales and distribution platform offering dispensaries a complete suite of best in class brands, is partnering with Oakland-based Jetty Extracts (Jetty) to handle their distribution.

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the appointment of Reinhard von Roemeling, M.D., as Senior Vice President, Clinical Development, and Christine Guertin as Vice President, Regulatory Affairs & Quality Assurance

A head-to-head study directly comparing the pharmacokinetic (PK) profiles of two extended half-life (EHL) recombinant factor VIII (FVIII) therapies demonstrated improved PK characteristics for Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) compared to Eloctate® (recombinant FVIII fusion protein) in adult patients (n=17) with severe hemophilia A (excluding an outlier patient) who were previously treated with any factor VIII (FVIII) product.

The AZBio Pioneer Award for Lifetime Achievement is the highest honor awarded by Arizona’s bioscience community and is extended to an Arizonan whose body of work has made life better for people at home and around the world.

Partnership with Secure Exchange Solutions streamlines patient care delivery.

Happify Health, a leader in mental health technology and the emerging field of digital therapeutics, announced today the appointment of Murray Zucker, M.D. as Medical Director.

Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S.